Symptomatology of autism spectrum disorder in a population with neurofibromatosis type 1. - Wikidata - awgldk - TriplyDB

Symptomatology of autism spectrum disorder in a population with neurofibromatosis type 1.

Symptomatology of autism spectrum disorder in a population with neurofibromatosis type 1.

http://www.wikidata.org/entity/Q34481152

about

Neurofibromin Loss of Function Drives Excessive Grooming in Drosophila Social learning and amygdala disruptions in Nf1 mice are rescued by blocking p21-activated kinase Neurofibromatosis type 1 and chronic neurological conditions in the United States: an administrative claims analysis.Autism traits in the RASopathies.Transient inhibition of the ERK pathway prevents cerebellar developmental defects and improves long-term motor functions in murine models of neurofibromatosis type 1.Reverse Pathway Genetic Approach Identifies Epistasis in Autism Spectrum Disorders.Distribution and Within-Family Specificity of Quantitative Autistic Traits in Patients with Neurofibromatosis Type I.mTOR, a Potential Target to Treat Autism Spectrum Disorder.The role of ionotropic glutamate receptors in childhood neurodevelopmental disorders: autism spectrum disorders and fragile x syndrome.Using genetic findings in autism for the development of new pharmaceutical compounds.Cognitive and behavioral problems in children with neurofibromatosis type 1: challenges and future directions.Characterization of early communicative behavior in mouse models of neurofibromatosis type 1.CRMP2 is necessary for Neurofibromatosis type 1 related pain.Disease Burden and Symptom Structure of Autism in Neurofibromatosis Type 1: A Study of the International NF1-ASD Consortium Team (INFACT).Autism genetics - an overview.Executive functioning deficits in children with neurofibromatosis type 1: The influence of intellectual and social functioning.Role of SIRT1/PGC-1α in mitochondrial oxidative stress in autistic spectrum disorder.Brief Report: The Prevalence of Neurofibromatosis Type 1 among Children with Autism Spectrum Disorder Identified by the Autism and Developmental Disabilities Monitoring Network.Brain and behaviour phenotyping of a mouse model of neurofibromatosis type-1: an MRI/DTI study on social cognition.Dysregulated gene expressions of MEX3D, FOS and BCL2 in human induced-neuronal (iN) cells from NF1 patients: a pilot study.Autism spectrum disorder symptomatology in children with neurofibromatosis type 1.Cognitive and Behavioral Disorders in Children with Neurofibromatosis Type 1.Psychosocial Features of Neurofibromatosis Type 1 in Children and Adolescents.Emotional and behavioral problems in children and adolescents with neurofibromatosis type 1.Neurodevelopmental disorders in children with neurofibromatosis type 1.Impaired engagement of the ventral attention system in neurofibromatosis type 1.Autism spectrum disorder profile in neurofibromatosis type I.Autism Spectrum Disorder in an Unselected Cohort of Children with Neurofibromatosis Type 1 (NF1).Social functioning and facial expression recognition in children with neurofibromatosis type 1.Prevalence of Autism Spectrum Disorder symptoms in children with neurofibromatosis type 1.Visuoperceptual processing in children with neurofibromatosis type 1: True deficit or artefact?The genetic and neuroanatomical basis of social dysfunction: lessons from neurofibromatosis type 1.RASopathies are associated with a distinct personality profile.Update from the 2013 International Neurofibromatosis Conference.Social skills in children with RASopathies: a comparison of Noonan syndrome and neurofibromatosis type 1.CTF meeting 2012: Translation of the basic understanding of the biology and genetics of NF1, NF2, and schwannomatosis toward the development of effective therapies.Imaging genetics in neurodevelopmental psychopathology

P2860

Q27347271-871CDDF7-D435-45B8-9E61-0FFDA84E78E2 Q28592608-29081762-20D6-49FB-9A81-8F9805121D82 Q30394733-ECDC44F4-2645-4E3E-A4CD-A2B1D99A1BEA Q34503769-04518644-7611-4133-8052-0B6D8662C210 Q34980977-1DD75546-6917-433A-B93D-6C7F217A5FD0 Q36246158-BD125227-1F11-4FAB-BDD2-B4C9DE5E119F Q36688215-7CEA9429-A1BC-4583-8339-7B2DF66C9B74 Q37350523-82F74E34-F1E6-4D46-BB19-27E03D476A98 Q37559828-1BC69829-7275-4665-BCC4-6106119A0301 Q38167615-89DEAA68-CD34-4694-9B1E-3F1E60733155 Q38243763-F3E37AE8-876C-461E-95F7-CB214AB6F59D Q38607455-41AE8C72-2A61-48E6-97AA-B5B14FB02E80 Q38610238-5BF92C84-8FA2-4F89-8924-24906F90DF25 Q38808993-8E2D04DA-C38F-4ABA-9C14-9A872667CEB6 Q38981431-99D32C56-36E1-4377-846A-8DC490C5ABA9 Q40102129-EE384B04-799D-47A5-88C0-A4AB34F2B228 Q40128301-51B932B2-57E0-4E55-83BB-9D3ED2C7EA21 Q41646038-222717A2-A6CE-46CD-89E7-C94FDA276BD6 Q41721276-288AE6D6-4E03-4048-9B70-CF7BF56FFAF3 Q42639726-538697D5-E655-4922-A137-6A4C2612E3D9 Q43840704-77FDDF71-CB38-4CF9-AD5B-AAE1C3440F59 Q47150280-E7301D4A-3C76-4AF8-9B0A-02D6C74A4F46 Q47557393-C81623AF-F089-4DBA-9E4E-E32835CE52EC Q47574493-4263ECC2-55DA-4E2F-8974-1784A4652B80 Q47723947-EDCEBBF1-4A64-4F39-AEEE-DCA7DA9EFD4C Q48236073-C453285C-564C-4A50-B7F8-704AC5F647D5 Q48423864-41FF1C5E-9775-42F4-B36B-99A973A15A09 Q50104099-EC2A5011-7AD0-4AB4-9A23-813FBD87A1F7 Q50238336-3D1B5A8E-FB0C-444A-B827-4456A75F4C32 Q50303197-0F0C115F-8281-40A1-8296-011388B8862C Q50342399-F519D112-0265-4905-A486-70D303BDAEB7 Q51182588-D1480EB1-9115-4314-B749-9CBC5D0CC11F Q52320476-8F65230F-C683-4BE7-BE82-402EE65B3BBA Q53083642-3C7C58BB-238F-4596-BFCA-98B738ABEF74 Q55380232-CF9F5382-5C57-4EAF-AA9A-064ADDD9651C Q55638662-57C73B7A-C7C7-495E-B0E3-152F3B8F948E Q57317054-54B6D753-5527-4F56-BFA2-66FEE42639D0

P2860

Symptomatology of autism spectrum disorder in a population with neurofibromatosis type 1.

http://www.wikidata.org/entity/Q34481152

description

2012 nî lūn-bûn

@nan

2012 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Symptomatology of autism spectrum disorder in a population with neurofibromatosis type 1.

@ast

Symptomatology of autism spectrum disorder in a population with neurofibromatosis type 1.

@en

Symptomatology of autism spectrum disorder in a population with neurofibromatosis type 1.

@nl

type

label

Symptomatology of autism spectrum disorder in a population with neurofibromatosis type 1.

@ast

Symptomatology of autism spectrum disorder in a population with neurofibromatosis type 1.

@en

Symptomatology of autism spectrum disorder in a population with neurofibromatosis type 1.

@nl

prefLabel

Symptomatology of autism spectrum disorder in a population with neurofibromatosis type 1.

@ast

Symptomatology of autism spectrum disorder in a population with neurofibromatosis type 1.

@en

Symptomatology of autism spectrum disorder in a population with neurofibromatosis type 1.

@nl

P1433

Q34481152-D0470733-E90A-4670-8764-8A8FF8A8D29B

P1476

Q34481152-AB7C32F5-9438-4EDD-A6E3-A222CDF5EB67

P2093

Q34481152-149A4BD2-3B58-4791-BB52-6FF78D4F3143

Q34481152-27D854A3-0855-434E-9B3E-125F0D7E63D5

Q34481152-C44FB301-9814-4CC3-A082-C083EB2EC26A

Q34481152-E1AFBB3C-DEAA-476A-876C-2B2E4CA4F463

P2860

Q34481152-185212A9-C07D-436E-A0D8-B7C3DF347810

Q34481152-1FA9A77A-9EFF-4E34-A2CC-95AAFF126AE0

Q34481152-242EEA98-AEA3-48B7-ACFC-42747C739A51

Q34481152-35E35027-54E6-4169-AF07-5DA88BE0B1BF

Q34481152-385BC77E-A22F-4BC6-ADCC-6F752BB2B54D

Q34481152-40E2DCB9-B802-4B33-BF0A-357EA49D3D77

Q34481152-4786CA19-7377-4E95-8E13-5600C44CF035

Q34481152-52A3B962-3698-4C9D-A135-E4E0F4042BFD

Q34481152-54F41195-CE98-4598-8DC7-1276D8DD9A45

Q34481152-550B8F61-0793-4C46-8A4D-AF25CB18BD9D

P304

Q34481152-B5762FAD-8F0F-49B0-B44C-6D1EEAF6018C

P31

Q34481152-D24CAD33-5528-4321-BF6C-C59009036FF6

P356

Q34481152-89032505-7B07-4C4A-A5AB-F4036516E57E

P433

Q34481152-0924F15B-73DA-4035-A685-FEB85B5F551F

P478

Q34481152-31268933-45F8-43FC-AE91-0C07D69CE599

P50

Q34481152-6B1F6002-A101-4837-A6E8-9FE4BD843846

Q34481152-81359990-161D-4324-85C5-D257ED6876D6

Q34481152-A5EC5950-65FF-4540-B640-153C43EF621D

Q34481152-B526F39D-4A5D-48BF-BBA0-4EA6C98A41EC

P577

Q34481152-A481F65F-9EC9-463D-83FB-58EBA854B4F4

P5875

Q34481152-31D51AB1-B1C9-4641-BD0A-3663AE565FE8

P698

Q34481152-C926CABD-D2C0-47F8-96C5-9E636AE39901

P921

Q34481152-652E15E3-C77B-4A93-86E4-6CF4BE181AF8

Q34481152-6D470BAB-7854-4649-91EB-358A483477E2

P356

P1433

Developmental Medicine and Child Neurology

P1476

Symptomatology of autism spectrum disorder in a population with neurofibromatosis type 1.

@en

P2093

Daniel M Imas

http://www.w3.org/2001/XMLSchema#string

Maria T Acosta

http://www.w3.org/2001/XMLSchema#string

Peter G Kardel

http://www.w3.org/2001/XMLSchema#string

Roger J Packer

http://www.w3.org/2001/XMLSchema#string

P2860

A common variant of the latrophilin 3 gene, LPHN3, confers susceptibility to ADHD and predicts effectiveness of stimulant medication

Social and emotional problems in children with neurofibromatosis type 1: evidence and proposed interventions.

Psychometric properties of the Vanderbilt ADHD diagnostic parent rating scale in a referred population.

The nature and frequency of cognitive deficits in children with neurofibromatosis type 1.

The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2.

Cognitive deficits in neurofibromatosis 1.

Does cognitive impairment explain behavioral and social problems of children with neurofibromatosis type 1?

Examining autistic traits in children with ADHD: does the autism spectrum extend to ADHD?

Neurofibromatosis type 1: new insights into neurocognitive issues.

Peer problems in Attention Deficit Hyperactivity Disorder: current status and future directions.

P304

131-138

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/DMCN.12038

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

55

http://www.w3.org/2001/XMLSchema#string

P50

Francisco Xavier Castellanos

Maximilian Muenke

P577

2012-11-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

233722927

http://www.w3.org/2001/XMLSchema#string

P698

23163951

http://www.w3.org/2001/XMLSchema#string

P921

Autism spectrum